Acquisition Announced
Boston Scientific acquisition of Penumbra
US$15bn enterprise value
Announced 15 Jan 2026 · NYSE: PEN · US$374.00 cash and scrip per share
Advisers
Penumbra
Target
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Penumbra
- Acquirer
- Boston Scientific
- Target based in
- United States
- Buyer based in
- United States
- Equity value
- US$15bn
- Sector
- Medtech
In the league tables
Similar deals
- Danaher acquisition of Masimo Feb 2026 · US$9.9bn · Medtech
- KKR acquisition of Integer Holdings Aug 2026 · US$5.7bn · Medtech
- Thermo Fisher Scientific acquisition of Solventum purification and filtration (P&F) business Sep 2025 · US$4bn · Medtech
- Montagu acquisition of Teleflex Medical OEM Aug 2026 · US$1.5bn · Medtech
- AIP acquisition of Avanos Medical Apr 2026 · US$1.3bn · Medtech
Sources
- Jan 2026 Perella Weinberg Partners: Exclusive financial advisor to Penumbra on their sale to Boston Scientific $15B Pending pwpartners.com
- 15 Jan 2026 Press release (EX-99.2, exhibit), Boston Scientific announces agreement to acquire sec.gov
- 15 Jan 2026 Press release (EX-99.1, exhibit), Boston Scientific announces agreement sec.gov
- 15 Jan 2026 Penumbra $14.5 billion sale to Boston Scientific davispolk.com
- 15 Jan 2026 Press release (PR Newswire), Boston Scientific announces agreement to acquire Penumbra, Inc. prnewswire.com
- 1 Apr 2026 Definitive merger proxy statement (DEFM14A), Penumbra Inc sec.gov



